Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
03/2012
03/22/2012WO2012036287A1 Novel cortistatin a analog and use thereof
03/22/2012WO2012036278A1 Glycine transporter inhibitor
03/22/2012WO2012036276A1 Glycine transporter inhibitory substance
03/22/2012WO2012036253A1 Heterocyclic compounds for treating or preventing disorders caused by reduced neurotransmission of serotonin, norephnephrine or dopamine.
03/22/2012WO2012035436A1 Plinabulin prodrug analogs and therapeutic uses thereof
03/22/2012WO2012035171A2 New compounds
03/22/2012WO2012034961A1 Pyridine compounds for controlling invertebrate pests i
03/22/2012US20120071661 Ionic Liquid Solvents
03/22/2012US20120071657 Triazole compounds useful as protein kinase inhibitors
03/22/2012US20120071652 Novel Piperazines, Pharmaceutical Compositions and Methods of Use Thereof
03/22/2012US20120071529 Tetrazole Compounds Which Selectively Modulate The CB2 Receptor
03/22/2012US20120071523 Benzofuran-4,5-diones as selective peptide deformylase inhibitors
03/22/2012US20120071517 2-pyridinylethylcarboxamide derivatives and their use as fungicides
03/22/2012US20120071506 Methods for treating cns disorders with bicyclo-substituted 2-imidazoline and 2-imidazoles
03/22/2012US20120071487 Piperazine, piperidine and tetrahydropyridine derivatives and their pharmaceutical use
03/22/2012US20120071472 Riminophenazines with 2-(heteroaryl)amino substituents and their anti-microbial activity
03/22/2012US20120071466 Inhibitor compounds of 11-beta-hydroxysteroid dehydrogenase type 1
03/22/2012US20120070781 Base generator, photosensitive resin composition, pattern forming material comprising the photosensitive resin composition, pattern forming method using the photosensitive resin composition and products comprising the same
03/22/2012US20120070395 Novel amide derivative and whitening agent
03/22/2012CA2812089A1 Inhibitors of pi3k-delta and methods of their use and manufacture
03/22/2012CA2812088A1 Phtalazine derivatives as jak1 inhibitors
03/22/2012CA2811080A1 Heterocyclic compound
03/21/2012EP2431477A1 Polyketide compound
03/21/2012EP2431365A1 Azetidine compound and medicinal use thereof
03/21/2012EP2431361A1 Ascorbic acid aryl acetate/propionate ester, preparation method and pharmaceutical composition thereof
03/21/2012EP2431357A2 3-Aminopyrrolidine Derivatives as Modulators of Chemokine Receptors
03/21/2012EP2430014A1 Antiviral compounds
03/21/2012EP2430011A1 5-pyridin-3-yl-1,3-dihydro-indol-2-on derivatives and their use as modulators of aldosterone synthase and/or cyp11b1
03/21/2012EP2429997A1 2-azatriphenylene materials for organic light emitting diodes
03/21/2012EP2429993A1 Inhibitors of human immunodeficiency virus replication
03/21/2012EP2429991A1 Redox drug derivatives
03/21/2012EP2429987A2 Amide compound, preparation method thereof and pharmaceutical composition comprising same
03/21/2012EP2118093B1 [1,2,3]triazolyl substituted quinolines and coumarins as inhibitors of leukotriene biosynthesis
03/21/2012EP2079732B9 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist
03/21/2012EP2049493B1 Compounds suitable as modulators of hdl
03/21/2012EP1670766B1 Bicyclic imino acid derivatives for the treatment of (inter alia) diseases relating to the locomotor system
03/21/2012EP1439174B1 4-IMIDAZOLIN-2-ONE COMPOUNDS AS p38 MAP KINASE INHIBITORS
03/21/2012EP1422218B1 Antiviral agent
03/21/2012EP1248779B1 Glycosidase ihhibitors and preparation thereof
03/21/2012EP1233961B9 Method for producing 5-(1-piperazinyl)-benzofuran-2-carboxamide by transition metal-catalyzed amination
03/21/2012CN102388038A Benzofuranyl derivatives used as glucokinase inhibitors
03/21/2012CN102388023A Organic compounds and their uses
03/21/2012CN102382088A 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
03/21/2012CN102382063A 6-amino-5-cyano-pyrimidine-4-ones compound used for improving perception, power of concentration, learning efficiency, and/or memory power
03/21/2012CN102382037A Benzene propanoic acid compound and preparation method and medicine use thereof
03/21/2012CN102379872A Compounds, compositions and methods of inhibiting a-synuclein toxicity
03/21/2012CN102060819B Spiro 4-hydroxyfuran-2(5H)-one compound as well as preparation method and application thereof
03/21/2012CN101687800B Glucokinase activator
03/21/2012CN101513402B Antiviral agent
03/21/2012CN101495462B Pyrimidine derivatives and their use as pesticides
03/21/2012CN101007803B Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
03/20/2012US8138353 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
03/20/2012US8138206 Piperidine derivative
03/20/2012US8138182 Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient
03/20/2012CA2553423C Heterocyclic compounds for use in the treatment of cancer and the inhibition of angiogenesis
03/20/2012CA2505029C Isoindoline derivatives
03/20/2012CA2493225C Quinoline derivatives and their use as mycobacterial inhibitors
03/20/2012CA2405076C Dual molecules containing a peroxide derivative, synthesis and therapeutic applications thereof
03/20/2012CA2396227C 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
03/15/2012WO2012034055A2 Compounds as c-met kinase inhibitors
03/15/2012WO2012033631A2 Roseobacticides and uses thereof
03/15/2012WO2012033548A2 Herbicidal bis-nitrogen-containing oxo and sulfono heterocycles
03/15/2012WO2012033435A1 Method, compound, pharmaceutical composition and drug for restoring memory lost in normal and pathological contexts
03/15/2012WO2012033374A2 Sulphonate precursor having a 1,2,3-triazolium salt, a production method therefor and an intramolecular nucleophilic fluorination reaction using the same
03/15/2012WO2012033195A1 Heterocyclic compound
03/15/2012WO2012033108A1 Light-emitting element and electronic device
03/15/2012WO2012032389A2 Process for preparation of substantially pure fosamprenavir calcium and its intermediates
03/15/2012WO2011146589A8 Vitamin e conjugates, and their uses as antioxidants and prodrug delivery vehicles
03/15/2012WO2011133659A3 Inhibitors of hif and angiogenesis
03/15/2012WO2011131748A3 Benzimidazole derivatives as inhibitors of glutaminyl cyclase
03/15/2012US20120065395 2,4 (4,6) pyrimidine derivatives
03/15/2012US20120065216 Quinazolinedione derivatives as parp inhibitors
03/15/2012US20120065204 Novel n-hydroxy-benzamids for the treatment of cancer
03/15/2012US20120065199 Substituted quinolines for use as vegf inhibitors
03/15/2012US20120065185 Substituted alkylamine derivatives and methods of use
03/15/2012US20120065173 Chemical compounds
03/15/2012US20120065168 Pharmaceutical Hypocholesterolemic Compositions
03/15/2012US20120064062 Inhibitors of bacterial plasminogen activators
03/15/2012US20120064032 Novel hydroxamates as therapeutic agents
03/15/2012US20120060926 Polymerizable fullerene derivative and their use in organic photovoltaic cells
03/15/2012CA2810528A1 Compounds as c-met kinase inhibitors
03/14/2012EP2428508A1 Diamino heterocyclic carboxamide compound
03/14/2012EP2428507A2 Cannabinoid receptor ligands
03/14/2012EP2427454A1 Phenoxymethyl heterocyclic compounds
03/14/2012EP2427444A1 Inhibitors of the renal outer medullary potassium channel
03/14/2012EP2427436A1 Substituted aromatic carboxamide and urea derivatives as vanilloid receptor ligands
03/14/2012EP2427434A1 Process for preparing bromo-substituted quinolines
03/14/2012EP1147104B1 Aromatic heterocyclic compounds as antiinflammatory agents
03/14/2012CN102378760A Method for producing hydroxymethyl diphenyloxiranes and corresponding 1-azolylmethyl-1,2-diphenyloxiranes
03/14/2012CN102378753A Plasminogen activator inhibitor-1 inhibitor
03/14/2012CN102372700A 1,5-disubstituted hexahydrotriazine compound, preparation method and application
03/14/2012CN102372699A Improved manufacturing method of 1, 3 a -two replacing pyrrolic compound salt
03/14/2012CN102372698A Phthalazinone derivative and its preparation method and use in medicine
03/14/2012CN102372661A Compound for organic optoelectronic device, organic light emmiting diode including the same and display including the light emmiting diode
03/14/2012CN101384559B Benzimidazole derivatives and their use for modulating the GABA-A receptor complex
03/13/2012US8134016 Method for purifying dianhydrides
03/13/2012US8134015 Compound inhibiting in vivo phosphorous transport and medicine containing the same
03/13/2012US8133894 N-benzyl-4-methyleneamino-3-hydroxy-2-pyridones
03/13/2012US8133888 Hydrazide containing taxane conjugates
03/13/2012US8133887 Oxaphenanthrene derivatives
1 ... 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 ... 694